Market Overview:
The global exome sequencing market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for exome sequencing services for the diagnosis of Mendelian diseases and rare syndromes, as well as for research on complex diseases. In addition, technological advancements in DNA sequencing platforms are also contributing to the growth of this market. On the basis of type, the global exome sequencing market is segmented into Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome and Roche Nimblegen SeqCap. The Illumina TruSeq Exome segment is expected to account for a major share of this market during the forecast period owing to its high accuracy and coverage. On the basis of application, this market is divided into Mendelian disease and rare syndrome gene discovery, research on complex diseases and mouse exome sequencing.
Product Definition:
Exome sequencing is the process of sequencing all of the protein-coding regions of the genome. This is important because it can help identify mutations that are responsible for disease.
Agilent HaloPlex:
HaloPlex is a new technology developed by Agilent Technologies that allows high throughput analysis of single nucleotide polymorphism (SNP) at the exome level. It utilizes an array-based technology to detect SNP with greater sensitivity and specificity than other technologies available in the market. The product has been launched recently and is currently undergoing clinical trials, which may result in its approval during 2012.
Agilent SureSelect:
SureSelect is a selection of single nucleotide polymorphism (SNP) microarrays that are based on the principle of hybridization. It helps in identifying SNPs with high accuracy and precision. Agilent SureSelect SNPlexome is an example of such an array, which helps in the identification and validation of novel human-specific non-coding RNAs (ncRNA).
Application Insights:
The research of complex diseases segment dominated the global market in 2017. This can be attributed to the rising prevalence of chronic diseases, such as cancer, diabetes and autoimmune disorders. In addition, a rise in private and government-sponsored clinical trials has also increased the demand for exome sequencing for disease diagnosis.
Mendelian disease and rare syndrome gene discovery is expected to be the fastest growing application over the forecast period due to an increase in number of rare disorder genes being identified through genome-wide screening projects conducted by various research groups worldwide. For instance, around 90% of all genetic mutations associated with NARP gene found so far are caused by single nucleotide polymorphism (SNPs). Similarly, about 95% of all known mutations associated with SLC6A4 gene are caused by SNPs alone which accounts for about 70% overall incidence rate among sporadic cancers worldwide making it a prime candidate for genome wide association studies (GWAS).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate of advanced technologies and well-established healthcare infrastructure. Moreover, increasing government funding for genetic research is also expected to contribute towards regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing awareness about early diagnosis in emerging economies such as China and India.
Some prominent participants operating across Asia Pacific are Illumina Ltd., Roche Diagnostics Corporation, Fujifilm Wako Pure Chemical Corp.
Growth Factors:
- Increasing demand for personalized medicine: The Exome Sequencing market is expected to benefit from the increasing demand for personalized medicine. This is because Exome Sequencing can help in the diagnosis and treatment of genetic disorders.
- Technological advancements: The development of new technologies that can help in the sequencing of exomes is expected to drive growth in the Exome Sequencing market.
- Rising prevalence of genetic disorders: The rising prevalence of genetic disorders is expected to create a high demand for Exome Sequencing services, which will drive growth in this market.
- Growing awareness about exomes: There has been an increase in awareness about exomes among healthcare professionals and patients, which is likely to fuel growth in the Exome Sequencing market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Exome Sequencing Market Research Report
By Type
Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits
By Application
Mendelian disease and rare syndrome gene discovery, The research of complex diseases, Mouse exome sequencing
By Companies
Illumina TruSeq Exome, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Exome Sequencing Market Report Segments:
The global Exome Sequencing market is segmented on the basis of:
Types
Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mendelian disease and rare syndrome gene discovery, The research of complex diseases, Mouse exome sequencing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina TruSeq Exome
- Thermo Fisher
- Roche
- Angilent
- Eurofins
- Sengenics
- Ambry
- Macrogen
- BGI
- Novo Gene
Highlights of The Exome Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Agilent HaloPlex
- Agilent SureSelect
- Agilent SureSelect QXT
- Illumina TruSeq Exome
- Roche Nimblegen SeqCap
- MYcroarray MYbaits
- By Application:
- Mendelian disease and rare syndrome gene discovery
- The research of complex diseases
- Mouse exome sequencing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Exome Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Exome sequencing is a type of genetic testing that uses DNA from the exomes, or protein-coding regions of chromosomes. This type of testing can identify mutations in specific genes.
Some of the major companies in the exome sequencing market are Illumina TruSeq Exome, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene.
The exome sequencing market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Exome Sequencing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Exome Sequencing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Exome Sequencing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Exome Sequencing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Exome Sequencing Market Size & Forecast, 2018-2028
4.5.1 Exome Sequencing Market Size and Y-o-Y Growth
4.5.2 Exome Sequencing Market Absolute $ Opportunity
Chapter 5 Global Exome Sequencing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Exome Sequencing Market Size Forecast by Type
5.2.1 Agilent HaloPlex
5.2.2 Agilent SureSelect
5.2.3 Agilent SureSelect QXT
5.2.4 Illumina TruSeq Exome
5.2.5 Roche Nimblegen SeqCap
5.2.6 MYcroarray MYbaits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Exome Sequencing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Exome Sequencing Market Size Forecast by Applications
6.2.1 Mendelian disease and rare syndrome gene discovery
6.2.2 The research of complex diseases
6.2.3 Mouse exome sequencing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Exome Sequencing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Exome Sequencing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Exome Sequencing Analysis and Forecast
9.1 Introduction
9.2 North America Exome Sequencing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Exome Sequencing Market Size Forecast by Type
9.6.1 Agilent HaloPlex
9.6.2 Agilent SureSelect
9.6.3 Agilent SureSelect QXT
9.6.4 Illumina TruSeq Exome
9.6.5 Roche Nimblegen SeqCap
9.6.6 MYcroarray MYbaits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Exome Sequencing Market Size Forecast by Applications
9.10.1 Mendelian disease and rare syndrome gene discovery
9.10.2 The research of complex diseases
9.10.3 Mouse exome sequencing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Exome Sequencing Analysis and Forecast
10.1 Introduction
10.2 Europe Exome Sequencing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Exome Sequencing Market Size Forecast by Type
10.6.1 Agilent HaloPlex
10.6.2 Agilent SureSelect
10.6.3 Agilent SureSelect QXT
10.6.4 Illumina TruSeq Exome
10.6.5 Roche Nimblegen SeqCap
10.6.6 MYcroarray MYbaits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Exome Sequencing Market Size Forecast by Applications
10.10.1 Mendelian disease and rare syndrome gene discovery
10.10.2 The research of complex diseases
10.10.3 Mouse exome sequencing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Exome Sequencing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Exome Sequencing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Exome Sequencing Market Size Forecast by Type
11.6.1 Agilent HaloPlex
11.6.2 Agilent SureSelect
11.6.3 Agilent SureSelect QXT
11.6.4 Illumina TruSeq Exome
11.6.5 Roche Nimblegen SeqCap
11.6.6 MYcroarray MYbaits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Exome Sequencing Market Size Forecast by Applications
11.10.1 Mendelian disease and rare syndrome gene discovery
11.10.2 The research of complex diseases
11.10.3 Mouse exome sequencing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Exome Sequencing Analysis and Forecast
12.1 Introduction
12.2 Latin America Exome Sequencing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Exome Sequencing Market Size Forecast by Type
12.6.1 Agilent HaloPlex
12.6.2 Agilent SureSelect
12.6.3 Agilent SureSelect QXT
12.6.4 Illumina TruSeq Exome
12.6.5 Roche Nimblegen SeqCap
12.6.6 MYcroarray MYbaits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Exome Sequencing Market Size Forecast by Applications
12.10.1 Mendelian disease and rare syndrome gene discovery
12.10.2 The research of complex diseases
12.10.3 Mouse exome sequencing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Exome Sequencing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Exome Sequencing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Exome Sequencing Market Size Forecast by Type
13.6.1 Agilent HaloPlex
13.6.2 Agilent SureSelect
13.6.3 Agilent SureSelect QXT
13.6.4 Illumina TruSeq Exome
13.6.5 Roche Nimblegen SeqCap
13.6.6 MYcroarray MYbaits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Exome Sequencing Market Size Forecast by Applications
13.10.1 Mendelian disease and rare syndrome gene discovery
13.10.2 The research of complex diseases
13.10.3 Mouse exome sequencing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Exome Sequencing Market: Competitive Dashboard
14.2 Global Exome Sequencing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina TruSeq Exome
14.3.2 Thermo Fisher
14.3.3 Roche
14.3.4 Angilent
14.3.5 Eurofins
14.3.6 Sengenics
14.3.7 Ambry
14.3.8 Macrogen
14.3.9 BGI
14.3.10 Novo Gene
